Japan's Sekisui To Push Asian IVD Expansion With Veredus Buy
In line with its midterm growth strategy, the medical arm of Japanese chemicals group Sekisui Chemical has acquired Veredus Laboratories, a Singapore-based specialist in rapid and affordable multiplex molecular diagnostic systems. The acquisition will further strengthen Sekisui's presence in China, a key territory for the group and one of the main markets for Veredus' products.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.